1. University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK;
2. University Hospitals Seidman Cancer Center, Cleveland, OH;
3. Center for International Blood and Marrow Transplant Research, Department of Medicine, and
4. Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI;
5. Adult Bone Marrow Transplant, University Hospitals Bristol National Health Service Trust, Bristol, UK;
6. New York University Langone Health, New York, NY;
7. Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA;
8. Division of Cell Therapy and Hematology, Department of Medicine, Duke University Medical Center, Durham, NC;
9. Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC;
10. Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK;
11. Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD;
12. Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY;
13. Hematology Department, Institut Catalá d’Oncologia-Hospitalet, Barcelona, Spain;
14. Institut d’Investigació Biomédica de Bellvitge-Institut Català d’Oncologia, l’Hospitalet de Llobregat, El Prat de Llobregat, Spain;
15. Yale New Haven Hospital, New Haven, CT;
16. The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE;
17. Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;
18. Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada;
19. Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;
20. Division of Hematology, Oncology and Stem Cell Transplant, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL;
21. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL;
22. Deparment of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC;
23. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA;
24. Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL;
25. University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH;
26. Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS;
27. The Ottawa Hospital Transplant and Cellular Therapy Program, Ottawa, ON, Canada;
28. Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain;
29. Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA;
30. Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;
31. Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA;
32. Division of Clinical Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain;
33. Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA;
34. Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;
35. Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia;
36. Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA;
37. Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD;
38. City of Hope Medical Center, Duarte, CA;
39. Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL;
40. Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL;
41. Division of Hematology, Oncology and Blood & Marrow Transplantation, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;
42. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA;
43. The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA;
44. Department of Medicine, University of British Columbia, Vancouver, BC, Canada;
45. Maastricht University Medical Center, Maastricht, The Netherlands;
46. Department of Medicine, University of Rochester Medical Center, Rochester, NY;
47. Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;
48. Markey Cancer Center, University of Kentucky, Lexington, KY;
49. Department of Hematology, Centre Hospitalier Universitaire Grenoble Alpes, Université Grenoble Alpes, Grenoble, France;
50. Division of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea;
51. University of Texas Health Science Center at San Antonio, San Antonio, TX;
52. Division of Allergy, Immunology, and Blood and Marrow Transplant, University of California San Francisco Benioff Children’s Hospitals, San Francisco, CA;
53. Department of Medical Oncology, Division of Hematological Malignancies, Thomas Jefferson University, Philadelphia, PA;
54. Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL;
55. Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;
56. Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden;
57. Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands;
58. Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN;
59. Translational Cell Therapy Group, Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden;
60. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;
61. Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA;
62. The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH;
63. Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
64. Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL;
65. Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan;
66. Christian Medical College, Vellore, India;
67. Children’s Hospital Los Angeles, Los Angeles, CA;
68. Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH;
69. Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN;
70. Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;
71. Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;
72. Divisions of Hematology/Oncology and Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; and
73. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN